Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
Hypertension is a worldwide epidemic that continues to grow, with a subset of patients responding poorly to current treatment available. This is especially relevant in Asia, which constitutes 61% of the global population. Hypertension in Asia is a unique entity that is often salt-sensitive, nocturna...
Saved in:
Main Authors: | Lin, Donna S-H, Wang, Tzung-Dau, Buranakitjaroen, Peera, Chen, Chen-Huan, Cheng, Hao-Min, Chia, Yook Chin, Sukonthasarn, Apichard, Tay, Jam Chin, Teo, Boon Wee, Turana, Yuda, Wang, Ji-Guang, Kario, Kazuomi, Network, HOPE Asia |
---|---|
Format: | Article |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/34533/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics and control of the 24-hour ambulatory blood pressure in patients with metabolic syndrome
by: Huang, Jian-Feng, et al.
Published: (2021) -
Hypertension and erectile dysfunction: The role of endovascular therapy in Asia
by: Wang, Tzung-Dau, et al.
Published: (2021) -
Hypertension in a multi-ethnic Asian population of Singapore
by: Chan, Gek Cher, et al.
Published: (2021) -
Hypertension and stroke in Asia: A comprehensive review from HOPE Asia
by: Turana, Yuda, et al.
Published: (2021) -
The feasibility of polypill for cardiovascular disease prevention in Asian Population
by: Sukonthasarn, Apichard, et al.
Published: (2021)